Emerging roles of the cGAS/STING pathway in cardiovascular diseases
Cardiovascular diseases (CVDs) remain the leading cause of mortality and morbidity worldwide, highlighting the need for novel therapeutic approaches. Inflammation plays a key role in CVD…
Read the full articleYou might also wanna read
Genome-wide association study of coronary flow reserve assessed by cardiac perfusion PET suggests a role for NF-κB pathway
Study links NF-κB pathway to coronary microvascular disease via cardiac PET, analyzing 2-stage GWAS for deeper IHD insight. PMID:42231019, N
A Metabolic Pathway Modifies Immune Responses and Associates with Cardiovascular Disease in Lupus
A Metabolic Pathway Modifies Immune Responses and Associates with Cardiovascular Disease in Lupus hfabryova Wed, 11/27/2024 - 10:52 November
Pink1-mediated mitophagy in the endothelium releases proteins encoded by mitochondrial DNA and activates neutrophil responses during inflammation
Eukaryotic mitochondria are characterized by several features that represent vestiges of their prokaryotic ancestry. One such feature is the
Rational design of carbazole-based STING inhibitors for treating cGAS-STING pathway-driven inflammatory disorders
Carbazole-based STING inhibitor DDO-88109 demonstrated potential in targeting autoimmune inflammation, with enhanced specificity and reduced
Mitochondrial flagella-like extensions (MitoFLARE) dysfunction triggers STING-mediated immune dysregulation in sepsis
Study uncovers MitoFLARE dysfunction in sepsis, linking mitochondrial restructuring to immune chaos. Early LPS triggers mitochondria to rele
Cdh1 stabilizes STING to boost innate immune activation in renal cell carcinoma, study finds
The E3 ubiquitin ligase APC/C with its coactivator Cdh1 is generally considered to be a tumor suppressor, regulating genome stability and th
scim.ag·20d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.